Cabazitaxel in Patients With Recurrent Ovarian Cancer After Failure of Standard Therapy.

NCT02560337 · clinicaltrials.gov ↗
PHASE2
Phase
COMPLETED
Status
26
Enrollment
OTHER
Sponsor class

Conditions

Interventions

Sponsor

Vejle Hospital